RenaissanceRe Holdings Ltd . (NYSE: NYSE:RNR) reported fourth quarter earnings that beat analyst expectations, while revenue fell short of estimates.

The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...

Chubb (NYSE:CB) posted on Tuesday Q4 earnings that surpassed Wall Street expectations as the property and casualty insurer recorded lower catastrophe losses and an improved combined ratio. Q4 core ...

Tom Lee, Fundstrat Global Advisors managing partner and head of research, appeared on CNBC to talk about his 2025 playbook.

Shares of off-Road and powersports vehicle corporation Polaris (NYSE:PII) fell 8.3% in the morning session after the company ...

We recently published a list of 10 AI News And Ratings on Wall Street’s Radar. In this article, we are going to take a look ...

Shares of data warehouse-as-a-service Snowflake (NYSE:SNOW) jumped 7.3% in the morning session as the debate around the ...

Rubrik’s 38% YoY growth and momentum in cyber resilience offer solid prospects. Learn why RBRK stock is a buy with a $110 ...

Nvidia and other U.S. tech stocks are holding steadier Tuesday, a day after tumbling on doubts about whether ...

Onvo, Nio's second brand, launched in May with production starting in September. Firefly, Nio's third brand, launched in ...

Dividend stocks provide investors with reliable streams of passive income. Passive income is characterized by its ability to ...

10:30 a.m. Atlanta Fed GDPNow fourth quarter update.